NEUROPATHIX, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 16 rows, 16 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-03-12: Reporting owner PETKANAS DEAN; Form 4/A; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-03-12: Reporting owner KIKIS THOMAS EVANGELOS; Form 4/A; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-03-12: Reporting owner MALASEK ROBERT; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-03-12: Reporting owner Scott Timothy Richard; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-03-12 | PETKANAS DEAN Director, Officer (Chief Executive Officer) | 4/A | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,450,000 1,450,000 owned after | $0.13 exercise price | 2021-03-18 | |
| 2021-03-12 | KIKIS THOMAS EVANGELOS Director, Officer (Chief Communication Officer) | 4/A | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +800,000 800,000 owned after | $0.13 exercise price | 2021-03-18 | |
| 2021-03-12 | MALASEK ROBERT Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +600,000 600,000 owned after | $0.13 exercise price | 2021-03-16 | |
| 2021-03-12 | Scott Timothy Richard Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +600,000 600,000 owned after | $0.13 exercise price | 2021-03-16 | |
| 2021-03-12 | Schroeder Blake Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +600,000 600,000 owned after | $0.13 exercise price | 2021-03-16 | |
| 2021-03-12 | Corrao Mark Officer (Chief Financial Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +800,000 800,000 owned after | $0.13 exercise price | 2021-03-16 | |
| 2021-03-12 | KIKIS THOMAS EVANGELOS Director, Officer (Chief Communication Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +800,000 800,000 owned after | $0.13 exercise price | 2021-03-16 | |
| 2021-03-12 | PETKANAS DEAN Director, Officer (Chief Executive Officer) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,450,000 1,450,000 owned after | $0.13 exercise price | 2021-03-16 | |
| 2021-03-12 | KINNEY WILLIAM Officer (Chief Scientific Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +900,000 900,000 owned after | $0.13 exercise price | 2021-03-16 | |
| 2020-05-04 | KIKIS THOMAS EVANGELOS Director, Officer (Chief Communications Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +800,000 800,000 owned after | $0.57 exercise price | 2020-05-06 | |
| 2020-05-04 | Scott Timothy Richard Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $0.57 exercise price | 2020-05-06 | |
| 2020-05-04 | Schroeder Blake Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $0.57 exercise price | 2020-05-06 | |
| 2020-05-04 | PETKANAS DEAN Director, Officer (Chief Executive Officer), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,450,000 1,450,000 owned after | $0.57 exercise price | 2020-05-06 | |
| 2020-05-04 | MALASEK ROBERT Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $0.57 exercise price | 2020-05-06 | |
| 2020-05-04 | KINNEY WILLIAM Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +900,000 900,000 owned after | $0.57 exercise price | 2020-05-06 | |
| 2020-05-04 | Corrao Mark Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +800,000 800,000 owned after | $0.57 exercise price | 2020-05-06 |